Table 2.
Age, y |
||||||||
---|---|---|---|---|---|---|---|---|
Viral Target | 0-1 | 2-6 | 7-12 | 13-19 | 20-39 | 40-59 | 60-79 | >80 |
Influenza A H3 | 5 | 6 | 11 | 5 | 16 | 10 | 12 | 6 |
Influenza A H1N1 2009 | 0 | 1 | 0 | 2 | 5 | 3 | 3 | 0 |
Influenza B | 1 | 1 | 0 | 1 | 3 | 3 | 5 | 0 |
RSV A | 36 | 14 | 0 | 0 | 1 | 6 | 6 | 1 |
RSV B | 11 | 8 | 2 | 1 | 2 | 8 | 5 | 1 |
PIV-1 | 2 | 0 | 2 | 0 | 2 | 0 | 1 | 0 |
PIV-2 | 4 | 1 | 2 | 0 | 5 | 5 | 3 | 0 |
PIV-3 | 26 | 7 | 1 | 0 | 6 | 13 | 9 | 0 |
hMPV | 20 | 13 | 6 | 3 | 5 | 9 | 14 | 3 |
ADV B/E | 2 | 3 | 0 | 0 | 1 | 2 | 0 | 0 |
ADV C | 23 | 8 | 1 | 0 | 3 | 5 | 2 | 0 |
HRV | 123 | 91 | 35 | 17 | 56 | 59 | 62 | 6 |
Total detected viruses | 253 | 153 | 60 | 29 | 105 | 123 | 122 | 17 |
Total specimens tested | 344 | 195 | 106 | 107 | 322 | 549 | 538 | 76 |
Viral targets detected per total specimens tested, % | 73.5 | 78.4 | 56.6 | 27.1 | 32.6 | 22.4 | 22.7 | 22.3 |
ADV B/E, adenovirus species B/E; ADV C, adenovirus species C; hMPV, human metapneumovirus; HRV, human rhinovirus; PIV-1, parainfluenza virus 1; PIV-2, parainfluenza virus 2; PIV-3, parainfluenza virus 3; RSV A, respiratory syncytial virus subtype A; RSV B, respiratory syncytial virus subtype B.
aValues are presented as numbers unless otherwise indicated.